We further demonstrate that lymph node associated signals (IL-4 + CD40L) inhibit NK cell activation against CLL cells via upregulation of HLA-E, and that inhibition of XPO1 can overcome this protective effect. The gene discussed is XPO1; the disease is B-cell chronic lymphocytic leukemia.